» Articles » PMID: 15142474

The Interface of Psychiatry and Irritable Bowel Syndrome

Overview
Publisher Current Science
Specialty Psychiatry
Date 2004 May 15
PMID 15142474
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The interface of psychiatry and irritable bowel syndrome (IBS) is well established, with psychiatric comorbidity approaching 20% to 60%. Anxiety disorders, depressive disorders, and somatoform disorders are the more frequently occurring comorbid conditions. Moreover, psychosocial stressors and history of trauma and abuse play a significant role in the onset and perpetuation of IBS symptoms. The psychiatric management of IBS more effectively uses a collaborative approach between a mental health practitioner and a primary care clinician or gastroenterologist. Psychiatric treatment includes the use of pharmacotherapy with antidepressants or anxiolytics, psychotherapy, and attention to psychosocial stressors. Psychiatric interventions have consistently demonstrated effectiveness in reducing IBS symptoms and improvement of patient functioning.

Citing Articles

A Cross-Sectional Study of the Prevalence of Irritable Bowel Syndrome and Its Association With Anxiety and Depression Among Nurses in the Al-Qassim Region of Saudi Arabia.

Alqifari A, Alharbi S, Alayed F, Alabdullatif N, Aljardan S, Alqifari H Cureus. 2024; 16(9):e70278.

PMID: 39469355 PMC: 11516225. DOI: 10.7759/cureus.70278.


Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial.

Shahkaram H, Sarani Yaztappeh J, Sadeghi A, Kianimoghadam A, Soltanabadi S, Bakhtiari M BMC Gastroenterol. 2024; 24(1):66.

PMID: 38321387 PMC: 10845775. DOI: 10.1186/s12876-024-03142-w.


Buspirone in the management of refractory irritable bowel syndrome: A case report.

Abdul Karim M, Al-Baz N, Haddad P, Reagu S, Alabdulla M Medicine (Baltimore). 2021; 100(51):e28003.

PMID: 34941040 PMC: 8701920. DOI: 10.1097/MD.0000000000028003.


Gut microbiome composition and diversity are related to human personality traits.

Johnson K Hum Microb J. 2021; 15:None.

PMID: 34435164 PMC: 8336012. DOI: 10.1016/j.humic.2019.100069.


Pharmacological restoration of gut barrier function in stressed neonates partially reverses long-term alterations associated with maternal separation.

Rincel M, Olier M, Minni A, Monchaux de Oliveira C, Matime Y, Gaultier E Psychopharmacology (Berl). 2019; 236(5):1583-1596.

PMID: 31147734 DOI: 10.1007/s00213-019-05252-w.


References
1.
Lydiard R, Falsetti S . Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials. Am J Med. 1999; 107(5A):65S-73S. DOI: 10.1016/s0002-9343(99)00082-0. View

2.
OSULLIVAN M, Mahmud N, Kelleher D, Lovett E, OMorain C . Patient knowledge and educational needs in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2000; 12(1):39-43. DOI: 10.1097/00042737-200012010-00008. View

3.
Ferguson A, Sircus W, Eastwood M . Frequency of "functional" gastrointestinal disorders. Lancet. 1977; 2(8038):613-4. DOI: 10.1016/s0140-6736(77)91466-0. View

4.
Guthrie E, Creed F, Whorwell P, Tomenson B . Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders. Gut. 1992; 33(3):361-3. PMC: 1373828. DOI: 10.1136/gut.33.3.361. View

5.
Olden K . Diagnosis of irritable bowel syndrome. Gastroenterology. 2002; 122(6):1701-14. DOI: 10.1053/gast.2002.33741. View